Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.01% | 1.52% | 3.26% | 5.65% | -73.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.01% | 1.52% | 3.26% | 5.65% | -73.83% |
| Cost of Revenue | 6.54% | 5.63% | 3.76% | 4.85% | -82.65% |
| Gross Profit | -2.92% | -2.89% | 2.71% | 6.56% | -41.57% |
| SG&A Expenses | 0.58% | -2.38% | -0.77% | -2.90% | -40.56% |
| Depreciation & Amortization | 320.99% | -- | -25.28% | -45.02% | -65.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.42% | 0.81% | 1.33% | 0.34% | -75.06% |
| Operating Income | -61.73% | 10.30% | 36.57% | 224.82% | -37.91% |
| Income Before Tax | 97.36% | -479.44% | -795.90% | 72.07% | -1,538.47% |
| Income Tax Expenses | -95.06% | 750.83% | 58.87% | 73.23% | 828.23% |
| Earnings from Continuing Operations | 97.15% | -544.65% | -1,143.28% | 71.55% | -1,966.06% |
| Earnings from Discontinued Operations | -231.16% | -931.07% | -3,019.61% | -149.29% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 80.98% | -1,076.79% | -2,623.21% | -14.15% | -1,765.07% |
| EBIT | -61.73% | 10.30% | 36.57% | 224.82% | -37.91% |
| EBITDA | 40.35% | 6.88% | 8.71% | 23.53% | -74.63% |
| EPS Basic | 80.96% | -1,073.45% | -2,616.04% | -12.77% | -1,754.95% |
| Normalized Basic EPS | -122.75% | 24.88% | -58.78% | 310.14% | -46.94% |
| EPS Diluted | 80.83% | -1,073.45% | -2,601.87% | -13.81% | -1,754.74% |
| Normalized Diluted EPS | -122.75% | 27.13% | -58.78% | 310.14% | -45.91% |
| Average Basic Shares Outstanding | -0.05% | 0.26% | 0.27% | 1.24% | 0.60% |
| Average Diluted Shares Outstanding | -0.05% | -1.51% | 0.27% | 1.24% | -1.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |